Company: BDRX
Filing Date: 2025-01-28
Form Type: 424B3
Source: 0001214659-25-001409
Chunk: 66

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-28
Form: 424B3
Chunk 66
---
 doing business internationally.

We
have in the past, and may in the future, operate outside of the United Kingdom. These international operations are subject to a number
of risks inherent in operating in different countries. These include, but are not limited to, risks regarding:

| • | currency exchange rate fluctuations; |

| • | restrictions on repatriation of earnings; |

| • | difficulty of effective enforcement of contractual provisions in local jurisdictions; |

| • | inadequate intellectual property (including confidentiality) protection in foreign countries; |

| • | public health epidemics or outbreaks, such as COVID-19; |

| • | trade-protection measures, import or export licensing requirements and fines, penalties or suspension or 
 revocation of export privileges; and                                                                     |

| • | changes in a specific country’s or a region’s political or economic conditions, including 
 the implications of the United Kingdom’s withdrawal from the European Union.              |

The occurrence of any of these events or conditions
could adversely affect our ability to increase or maintain our operations in various countries.

We are exposed to risks related to currency exchange rates.

We currently conduct a portion
of our operations outside of the United Kingdom. Because we use the British pound sterling as our financial statement reporting currency,
changes in currency exchange rates have had and could have a significant effect on our operating results when our operating results are
translated from the local currency into the British pound sterling. Exchange rate fluctuations between local currencies and the British
pound sterling create risk in several ways, including the following: weakening of the British pound sterling, as seen, for example, following
the results of the Brexit referendum, may increase the British pound sterling cost of overseas research and development expenses and the
cost of sourced product components outside the United Kingdom; strengthening of the British pound sterling may decrease the value of our
revenues denominated in other currencies; the exchange rates on non-sterling transactions and cash deposits can distort our financial
results; and commercial pricing and profit margins are affected by currency fluctuations. Future changes in currency exchange rates could
have a material adverse effect on our financial results.

We are subject to cybersecurity risks, including the misappropriation or compromise of our information, our information technology systems, and other cybersecurity incidents that may result in operational or service disruption, harm to our reputation, litigation, fines, penalties and liabilities, and the incurrence of costs in an effort to minimize those risks.

In the normal course of conducting
our business, we collect and store sensitive data on our networks and on